scholarly journals Breast cancer targeted/ therapeutic with double and triple fusion Immunotoxins

Author(s):  
Zoleikha Goleij ◽  
Hamideh Mahmoodzadeh Hosseini ◽  
Hamid Sedighian ◽  
Elham Behzadi ◽  
Raheleh Halabian ◽  
...  
Marine Drugs ◽  
2018 ◽  
Vol 16 (5) ◽  
pp. 157 ◽  
Author(s):  
Amira Goda ◽  
Abu Siddique ◽  
Mohamed Mohyeldin ◽  
Nehad Ayoub ◽  
Khalid El Sayed

2011 ◽  
Vol 3 (1) ◽  
pp. 163-171 ◽  
Author(s):  
LYNDSAY V. RHODES ◽  
SYREETA L. TILGHMAN ◽  
STEPHEN M. BOUE ◽  
SHUCHUN WANG ◽  
HAFEZ KHALILI ◽  
...  

Oncotarget ◽  
2014 ◽  
Vol 5 (10) ◽  
pp. 3145-3158 ◽  
Author(s):  
Fares Al-Ejeh ◽  
Mariska Miranda ◽  
Wei Shi ◽  
Peter T. Simpson ◽  
Sarah Song ◽  
...  

Author(s):  
Yu Zhang ◽  
Huan Deng

Metastasis is a major cause factor for breast cancer (BC)-associated mortality. During the metastatic process, disseminated tumor cells (DTCs) detach from the primary sites, and enter the bloodstream and establish the secondary colonies. Recent studies have provided substantial evidence for the importance of Notch signaling in BC metastasis. Therefore, this review focuses on the mechanisms by which Notch contributes to the origin of BC DTCs, increases their motility, regulates their intravasation and extravasation, protects them from host surveillance, and finally facilitates colonization. Identification of the mechanisms underlying Notch-related BC metastasis will lead to the development of novel Notch-targeted therapeutic strategies to reduce metastasis and significantly improve outcomes.


Author(s):  
J García ◽  
R García ◽  
O Villanueva ◽  
N Santos ◽  
D Barrera ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document